Navigation Links
Selexis Announces Expansion of R&D License Agreement with Amgen
Date:2/20/2013

GENEVA, Feb. 20, 2013 /PRNewswire/ -- Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins, announced today that Amgen has expanded their R&D License Agreement with Selexis to include an evaluation of the proprietary Selexis SURE CHO-M Cell Line™ for research and development.  Under the agreement, Amgen will be able to evaluate the SURE CHO-M Cell Line™ in conjunction with the Selexis SUREtech Vectors™ for improved R&D. 

(Logo: http://photos.prnewswire.com/prnh/20120627/LA31604LOGO)

"Successful protein expression in R&D is dependent upon a cell line development platform that is robust, high-yielding and stable," said Igor Fisch , Ph.D., President and CEO of Selexis. "Selexis is continually optimizing its proprietary cell line and technology platform to enable partners such as Amgen to make better R&D decisions by generating reliable data points faster and more cost efficiently.  This current agreement is built on the long-standing relationship between our two companies since 2004." 

About Selexis SA

Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with innovative technologies and world-class expert services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins. The Company's SUREtechnology Platform™ is based on Selexis Genetic Elements™ — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. Selexis has generated over 1,700 cell lines being used in a variety of programs from drug discovery to late-stage clinical trials.

For more information, visit http://www.selexis.com

Media Inquires
Robert Meister
Selexis SA
Tel: +1 (602) 953-1716
Email: robert.meister@selexis.com

 


'/>"/>
SOURCE Selexis SA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
2. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
3. Incisive Surgical Announces Sale Of One-Millionth INSORB Stapler
4. BioMed Realty Trust Announces Exercise Of Option To Purchase Additional Shares Of Common Stock
5. UBM Canon, the Global Authority on the MedTech Industry, Announces Senior Editor for MD+DI (Medical Device & Diagnostic Industry)
6. Silver Lining Textiles, Manufacturers of Anti-microbial Under Scrub Garments for the Healthcare Industry, Announces Their Availability Through Amazon.com
7. NxStage Announces CE Mark Approval for Nocturnal Home Hemodialysis
8. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
9. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
10. Vomaris Announces initiation of study with Walter Reed National Military Medical Centers Combat Wound Initiative
11. Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... Mass. (PRWEB) , ... November 11, 2019 , ... The ... among the Top 100 Women-Led Businesses in Massachusetts as published in the Boston Globe ... of CEO, Julie Turpin, who has held this position since 2014. , The ...
(Date:11/11/2019)... ... November 11, 2019 , ... iPatientCare, ... Management and Patient Engagement solutions, welcomed ConnectiveRX as a Silver Sponsor, and Upland ... 2019, held in Cincinnati, on October 18 - 19. The annual conference featured ...
(Date:11/9/2019)... ... November 09, 2019 , ... “Strong, silent” types with their ... much-loved, fictional British characters, like James Bond and Sherlock Holmes, and, let’s face ... calm stoicism, even in the most perilous and dire of situations? It's certainly ...
Breaking Medicine Technology:
(Date:11/12/2019)... , ... November 12, 2019 , ... ... group of individuals/organizations who have truly impacted those diagnosed with infertility. This year, ... prestigious Hope Award for Achievement, presented at the Night of Hope Gala in ...
(Date:11/12/2019)... TEMECULA, Calif. (PRWEB) , ... November 12, 2019 ... ... provides the most complete business management solution for physical therapy and rehabilitation operators ... in patient engagement technology with customers in 102 countries, today announces a joint ...
(Date:11/11/2019)... ... November 11, 2019 , ... Thermal Product Solutions, a global ... Depyrogenation Sterilizers to the Pharmaceutical Industry. The units will be used for ... with work chamber dimensions of 36” W x 36” D x 53” H. ...
(Date:11/11/2019)... ... ... PracticeLink Live! Atlanta Physician Career Fair will take place Thursday, November 14, 2019, at ... 8:00 p.m. A free, optional seminar for job-seeking physicians, residents and fellows, When to ... career fair and seminar are open to residents and fellows, as well as practicing ...
(Date:11/7/2019)... ... November 06, 2019 , ... Atlantic Ultraviolet Corporation makes it their business to ... flu shot. Since the flu season starts in October until March, Atlantic Ultraviolet makes ... employees can simply sign-up and get their shot. , Ann Wysocki, COO of Atlantic ...
Breaking Medicine News(10 mins):